Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly EBT Margin of 41124.75% for Q3 2025, down 3769560.0% year-over-year from N/an in Q3 2024, and down 56.95% quarter-over-quarter from 26202.07% in Q2 2025.
Dianthus Therapeutics (DNTH) EBT Margin (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 41124.75% for Q3 2025.
- In Q3 2025, EBT Margin fell 3769560.0% year-over-year to 41124.75%; the TTM figure through Sep 2025 stood at 9147.48% (down 504293.0% YoY), while the FY2024 annual figure was 4267.91%, up 163662.0% from the prior year.
- EBT Margin for Q3 2025 stood at 41124.75%, down from 26202.07% in the prior quarter.
- The five-year high for EBT Margin was 855.57% in Q4 2022, with the low at 41124.75% in Q3 2025.
- The 4-year median for EBT Margin is 3429.14% (2024), against an average of 7721.04%.
- Peak annual rise in EBT Margin reached 427720 bps in 2025, while the deepest fall reached 3769560 bps in 2025.
- Dianthus Therapeutics' EBT Margin stood at 855.57% in 2022, then tumbled by 188 bps to 2467.61% in 2023, then climbed by 14 bps to 2121.12% in 2024, then tumbled by 1839 bps to 41124.75% in 2025.
- Business Quant data shows DNTH's EBT Margin at 41124.75% in Q3 2025, 26202.07% in Q2 2025, and 3616.17% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -41,124.75% |
| Jun 30, 2025 | -26,202.07% |
| Mar 31, 2025 | -3,616.17% |
| Dec 31, 2024 | -2,121.12% |
| Sep 30, 2024 | -3,429.14% |
| Jun 30, 2024 | -3,488.84% |
| Mar 31, 2024 | -7,893.36% |
| Dec 31, 2023 | -2,467.61% |
| Sep 30, 2023 | -2,434.52% |
| Jun 30, 2023 | -1,109.40% |
| Mar 31, 2023 | -1,418.80% |
| Dec 31, 2022 | -855.57% |
| Sep 30, 2022 | -4,212.11% |